# Efficacy and Safety of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion

> **NCT00264927** · PHASE3 · COMPLETED · sponsor: **Sanofi** · enrollment: 77 (actual)

## Conditions studied

- Inappropriate ADH Syndrome
- Hyponatremia

## Interventions

- **DRUG:** SR121463B

## Key facts

- **NCT ID:** NCT00264927
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-05
- **Primary completion:** 2007-09
- **Final completion:** 2007-09
- **Target enrollment:** 77 (ACTUAL)
- **Last updated:** 2008-12-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00264927

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00264927, "Efficacy and Safety of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00264927. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*